PI
KERX

Putnam Investments’s Keryx Biopharmaceuticals Inc KERX Stock Holding History

Putnam Investments’s Portfolio KERX Stock Details KERX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-667,400
Closed -$3.54M – 1325
2016
Q3 		$3.54M Sell
667,400
-8,302
-1% -$44.8K 0.01% 680
2016
Q2 		$4.47M Hold
675,702
– – 0.01% 664
2016
Q1 		$3.16M Buy
675,702
+2,539
+0.4% +$10.1K 0.01% 815
2015
Q4 		$3.4M Hold
673,163
– – 0.01% 809
2015
Q3 		$2.37M Buy
673,163
+351,857
+110% +$2.36M 0.01% 943
2015
Q2 		$3.21M Buy
321,306
+166,946
+108% +$1.79M 0.01% 896
2015
Q1 		$1.97M Buy
+154,360
New +$1.98M ﹤0.01% 1059

Other funds holding KERX

BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Putnam Investments's KERX Position: Q4 2016 in Review

Putnam Investments sold out of Keryx Biopharmaceuticals Inc (KERX) in Q4 2016, closing a stake of 667,400 shares — an estimated $3.54M sold.

Putnam Investments first reported a position in KERX in Q1 2015 and held it in 7 quarters. The position peaked at $4.47M in Q2 2016. 123 funds tracked by Wall St. Rank hold KERX as of Q4 2016.

  • Putnam Investments reported no remaining Keryx Biopharmaceuticals Inc position as of Q4 2016 after selling out during the quarter.
  • Putnam Investments sold 667,400 Keryx Biopharmaceuticals Inc shares in Q4 2016, an estimated $3.54M.
  • Putnam Investments first reported a position in Keryx Biopharmaceuticals Inc in Q1 2015 and held it in 7 quarters.
  • Putnam Investments's Keryx Biopharmaceuticals Inc position peaked at $4.47M in Q2 2016.
  • 123 funds tracked by Wall St. Rank held Keryx Biopharmaceuticals Inc as of Q4 2016.

Based on Putnam Investments's 13F filing for Q4 2016, filed 14 Feb 2017.